Viewing Study NCT02296905


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-03-01 @ 1:29 AM
Study NCT ID: NCT02296905
Status: COMPLETED
Last Update Posted: 2015-10-21
First Post: 2014-11-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic Function
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatic Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatic Impairment View
None Hepatitis C Virus Infection View